|Transcatheter or surgical aortic-valve replacement in intermediate-risk patients|
MB Leon, CR Smith, MJ Mack, RR Makkar, LG Svensson, SK Kodali, ...
N Engl J Med 2016 (374), 1609-1620, 2016
|Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis|
VH Thourani, S Kodali, RR Makkar, HC Herrmann, M Williams, ...
The Lancet 387 (10034), 2218-2225, 2016
|Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients|
MJ Mack, MB Leon, VH Thourani, R Makkar, SK Kodali, M Russo, ...
New England Journal of Medicine 380 (18), 1695-1705, 2019
|Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study|
R Mehran, U Baber, PG Steg, C Ariti, G Weisz, B Witzenbichler, TD Henry, ...
The Lancet 382 (9906), 1714-1722, 2013
|Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature|
P Généreux, SJ Head, R Hahn, B Daneault, S Kodali, MR Williams, ...
Journal of the American College of Cardiology 61 (11), 1125-1136, 2013
|Protection against cerebral embolism during transcatheter aortic valve replacement|
SR Kapadia, S Kodali, R Makkar, R Mehran, RM Lazar, R Zivadinov, ...
Journal of the American College of Cardiology 69 (4), 367-377, 2017
|Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial)|
P Green, SV Arnold, DJ Cohen, AJ Kirtane, SK Kodali, DL Brown, ...
American Journal of Cardiology 116 (2), 264-269, 2015
|Transcatheter aortic valve implantation within degenerated aortic surgical bioprostheses: PARTNER 2 valve-in-valve registry|
JG Webb, MJ Mack, JM White, D Dvir, P Blanke, HC Herrmann, J Leipsic, ...
Journal of the American College of Cardiology 69 (18), 2253-2262, 2017
|Staging classification of aortic stenosis based on the extent of cardiac damage|
P Généreux, P Pibarot, B Redfors, MJ Mack, RR Makkar, WA Jaber, ...
European heart journal 38 (45), 3351-3358, 2017
|Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from …|
D Dvir, R Waksman, IM Barbash, SK Kodali, LG Svensson, EM Tuzcu, ...
Journal of the American College of Cardiology 63 (3), 269-279, 2014
|Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial)|
P Green, DJ Cohen, P Généreux, T McAndrew, SV Arnold, M Alu, ...
American Journal of Cardiology 112 (5), 700-706, 2013
|Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve|
P Pibarot, RT Hahn, NJ Weissman, M Arsenault, J Beaudoin, M Bernier, ...
JAMA cardiology 2 (11), 1208-1216, 2017
|Longitudinal hemodynamics of transcatheter and surgical aortic valves in the PARTNER Trial|
PS Douglas, MB Leon, MJ Mack, LG Svensson, JG Webb, RT Hahn, ...
JAMA cardiology 2 (11), 1197-1206, 2017
|Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low EF|
JJ Passeri, S Elmariah, K Xu, I Inglessis, JN Baker, M Alu, S Kodali, ...
Heart 101 (6), 463-471, 2015
|3-Year Outcomes After Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Bioprostheses: The PARTNER 2 Registry|
JG Webb, DJ Murdoch, MC Alu, A Cheung, A Crowley, D Dvir, ...
Journal of the American College of Cardiology 73 (21), 2647-2655, 2019
|Impact of short-term complications on mortality and quality of life after transcatheter aortic valve replacement|
SV Arnold, Y Zhang, SJ Baron, TC McAndrew, MC Alu, SK Kodali, ...
JACC: Cardiovascular Interventions 12 (4), 362-369, 2019
|Outcomes in 937 intermediate-risk patients undergoing surgical aortic valve replacement in PARTNER-2A|
VH Thourani, J Forcillo, WY Szeto, SK Kodali, EH Blackstone, AM Lowry, ...
The Annals of thoracic surgery 105 (5), 1322-1329, 2018
|Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts|
M Szerlip, S Gualano, E Holper, JJ Squiers, JM White, D Doshi, ...
JACC: Cardiovascular Interventions 11 (1), 13-20, 2018
|Transapical transcatheter aortic valve replacement is associated with increased cardiac mortality in patients with left ventricular dysfunction: insights from the PARTNER I trial|
S Elmariah, WF Fearon, I Inglessis, GJ Vlahakes, BR Lindman, MC Alu, ...
JACC: Cardiovascular Interventions 10 (23), 2414-2422, 2017
|CT-defined prosthesis–patient mismatch downgrades frequency and severity, and demonstrates no association with adverse outcomes after transcatheter aortic valve replacement|
J Mooney, SL Sellers, P Blanke, P Pibarot, RT Hahn, D Dvir, PS Douglas, ...
JACC: Cardiovascular Interventions 10 (15), 1578-1587, 2017